Aardvark Therapeutics, Inc. (AARD) stock
AARDNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.15−0.11 (-8.73%)
Close on Nov 17, 2026Market cap $25.17MP/E –Yield –
Aardvark Therapeutics operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Aardvark Therapeutics's operating cash flow for the twelve months ending Jun 30, 2026 was -$69.41M. For fiscal 2025 it was -$54.17M.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$54.17M | – |
| FY2024 | Dec 31, 2024 | -$18.09M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$17.60M | – |
| Q1 FY2026 | Mar 31, 2026 | -$18.87M | – |
| Q4 FY2025 | Dec 31, 2025 | -$16.81M | – |
| Q3 FY2025 | Sep 30, 2025 | -$16.13M | – |
| Q2 FY2025 | Jun 30, 2025 | -$9.84M | – |
| Q1 FY2025 | Mar 31, 2025 | -$11.39M | – |
| Q4 FY2024 | Dec 31, 2024 | -$7.73M | – |
| Q3 FY2024 | Sep 30, 2024 | -$3.96M | – |
| Q2 FY2024 | Jun 30, 2024 | -$4.22M | – |
| Q1 FY2024 | Mar 31, 2024 | -$2.19M | – |
See a number that looks wrong?